In summary, our data show that POGZ is essential for normal embryonic development and that loss of the gene leads to deregulation of embryonic globin expression, in part through Bcl11a. Reduction of POGZ expression in erythroid cells could have therapeutic implications in SCD and β-thalassemia. This evidence concerns the gene BCL11A and Schnyder corneal dystrophy.